Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT

v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)
Total
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated other comprehensive income (loss) [Member]
Accumulated Deficit [Member]
Treasury Stock [Member]
Non - controlling Interests [Member]
Beginning Balance at Dec. 31, 2021 $ (60,616,693)   $ 51,142,220 $ 0 $ (117,647,947) $ 0 $ 5,468,900
Beginning Balance, Shares at Dec. 31, 2021   420,134          
Share-based compensation from issuance of options and compensation-based warrants 312,166   312,166 0      
Exercise of stock options 77,900   75,795 0      
Exercise of stock options, Shares   2,105          
Accretion of 15.00% Series C preferred shares (2,664,462)   (2,664,462) 0      
Issuance of warrants 68,394,561   68,394,561 0      
Issuance of warrants in subsidiary 4,552,911     0     4,552,911
Deemed contribution in connection with issuance of preferred stock to Senior Lenders 9,942,069   9,942,069 0      
Foreign currency translation adjustment (2,327)     (2,327) 0    
Net loss (17,158,596)     0 (17,158,596) 0  
Ending Balance at Mar. 31, 2022 2,837,529   127,202,349 (2,327) (134,806,543) 0 10,021,811
Ending Balance, Shares at Mar. 31, 2022   422,239          
Beginning Balance at Dec. 31, 2021 (60,616,693)   51,142,220 0 (117,647,947) 0 5,468,900
Beginning Balance, Shares at Dec. 31, 2021   420,134          
Net loss (34,873,814)            
Ending Balance at Sep. 30, 2022 (1,425,346)   130,067,339 169,817 (152,521,761) 0 20,436,020
Ending Balance, Shares at Sep. 30, 2022   423,239          
Beginning Balance at Mar. 31, 2022 2,837,529   127,202,349 (2,327) (134,806,543) 0 10,021,811
Beginning Balance, Shares at Mar. 31, 2022   422,239          
Share-based compensation from issuance of options and compensation-based warrants 495,984   495,984 0      
Exercise of stock options 48,350   47,350 0      
Exercise of stock options, Shares   1,000          
Accretion of 15.00% Series C preferred shares (6,808,574)   (6,808,574) 0      
Foreign currency translation adjustment 16,618     16,618 0    
Net loss (2,400,783)     0 (2,400,783) 0  
Ending Balance at Jun. 30, 2022 (5,810,876)   120,937,109 14,291 (137,207,326) 0 10,021,811
Ending Balance, Shares at Jun. 30, 2022   423,239          
Share-based compensation from issuance of options and compensation-based warrants 737,141   737,141 0      
Revaluation of warrants 1,626,918   1,626,918        
Revaluation of warrants in subsidiary 10,414,209           10,414,209
Accretion of 15.00% Series C preferred shares (7,543,301)   (7,543,301) 0      
Issuance of warrants 14,309,472   14,309,472 0      
Foreign currency translation adjustment 155,526     155,526 0    
Net loss (15,314,435)     0 (15,314,435) 0  
Ending Balance at Sep. 30, 2022 (1,425,346)   130,067,339 169,817 (152,521,761) 0 20,436,020
Ending Balance, Shares at Sep. 30, 2022   423,239          
Beginning Balance at Dec. 31, 2022 (28,207,996)   122,632,584 72,514 (171,756,655) (15,935) 20,436,020
Beginning Balance, Shares at Dec. 31, 2022   423,476          
Share-based compensation from issuance of options and compensation-based warrants 613,260   613,260 0      
Exercise of stock options 4,595   4,543 0      
Exercise of stock options, Shares   52          
Accretion of 15.00% Series C preferred shares (8,879,091)   (8,879,091) 0      
Issuance of warrants 8,607,266   8,607,266 0      
Foreign currency translation adjustment 11,364     11,364 0    
Net loss (24,643,134)     0 (24,643,134) 0  
Ending Balance at Mar. 31, 2023 (52,493,736)   122,978,562 83,878 (196,399,789) (15,935) 20,436,020
Ending Balance, Shares at Mar. 31, 2023   423,528          
Beginning Balance at Dec. 31, 2022 (28,207,996)   122,632,584 72,514 (171,756,655) (15,935) 20,436,020
Beginning Balance, Shares at Dec. 31, 2022   423,476          
Net loss (59,954,697)            
Ending Balance at Sep. 30, 2023 (95,880,916)   115,675,547 (780,954) (231,711,352) 0 20,436,020
Ending Balance, Shares at Sep. 30, 2023   499,823          
Beginning Balance at Mar. 31, 2023 (52,493,736)   122,978,562 83,878 (196,399,789) (15,935) 20,436,020
Beginning Balance, Shares at Mar. 31, 2023   423,528          
Share-based compensation from issuance of options and compensation-based warrants 735,533   735,533 0      
Exercise of stock options 4,500   4,000 0      
Exercise of stock options, Shares   500          
Accretion of 15.00% Series C preferred shares (11,852,649)   (11,852,649) 0      
Issuance of warrants 9,882,205   9,882,205 0      
Foreign currency translation adjustment (25,465)     (25,465) 0    
Net loss (20,445,988)     0 (20,445,988) 0  
Ending Balance at Jun. 30, 2023 (74,195,600)   121,747,651 58,413 (216,845,777) (15,935) 20,436,020
Ending Balance, Shares at Jun. 30, 2023   424,028          
Share-based compensation from issuance of options and compensation-based warrants 715,094   715,094 0      
Conversion of convertible notes, Shares   75,795          
Conversion of convertible notes 1,167,676   1,075,946     15,935  
Accretion of 15.00% Series C preferred shares (11,502,360)   (11,502,360) 0      
Issuance of warrants 3,639,216   3,639,216 0      
Foreign currency translation adjustment (839,367)     (839,367) 0    
Net loss (14,865,575)     0 (14,865,575) 0  
Ending Balance at Sep. 30, 2023 $ (95,880,916)   $ 115,675,547 $ (780,954) $ (231,711,352) $ 0 $ 20,436,020
Ending Balance, Shares at Sep. 30, 2023   499,823